IPO window remains selective
US IPO hopefuls are reportedly continuing with listing plans despite market swings, and analysts expect activity to pick up if volatility eases, with high‑profile names like SpaceX and OpenAI cited as market watchers. Commentary suggests later‑stage tech companies are again preparing for public‑market timing, which can affect occupier decisions ahead of liquidity events. (economictimes.indiatimes.com) (investorplace.com)
The United States initial public offering market is open again, but only for companies that can show scale, profits or a near-term path to them. (money.usnews.com) Reuters reported on April 13 that companies from biotech to real estate investment trusts launched roadshows despite fresh market swings tied to conflict in the Middle East. Analysts told Reuters activity could pick up in coming months if volatility eases. (money.usnews.com) A roadshow is the sales pitch before a stock listing: executives meet investors, test demand and try to lock in a price range. The Securities and Exchange Commission says an initial public offering creates a public trading market for a company’s shares, usually with a listing on Nasdaq or the New York Stock Exchange. (sec.gov) The backdrop is better than it was a year ago, but not easy. EY said United States initial public offering activity increased in 2025, led by technology, media and telecommunications deals and strong investor interest in artificial intelligence, while its first-quarter 2026 report said global markets had become more selective because of geopolitics and investor expectations. (ey.com 1) (ey.com 2) That “selective” label shows up in the deal list. CoreWeave priced its March 2025 offering at $40 a share and raised $1.5 billion, the largest United States technology initial public offering since 2021, even after trimming the size of the sale. (coreweave.com) (cnbc.com) Other candidates have had to wait for calmer conditions. Reuters reported that StubHub delayed its roadshow earlier in 2025 when tariff-driven volatility froze dealmaking, then later drew orders more than 20 times the shares available when it returned. (finance.yahoo.com) Hinge Health is another example of the pipeline moving in fits and starts. The company had planned to go public in 2022, and Reuters reported in 2025 that it filed for a United States initial public offering as healthcare listings regained momentum; its investor relations site shows fresh Securities and Exchange Commission filings through April 2026. (newsbreak.com) (ir.hingehealth.com) The high-profile names that keep surfacing in market chatter are not the same as confirmed listings. OpenAI says it remains controlled by its nonprofit foundation and that its operating company is now a public benefit corporation, not a public company, while SpaceX has long resisted a near-term listing and has said Starlink would go public only when its cash flow becomes more predictable. (openai.com 1) (openai.com 2) That distinction matters because private-market fame does not guarantee public-market timing. Bankers can build a watch list around companies like OpenAI or SpaceX, but an actual initial public offering still depends on governance, audited financials, market stability and investor appetite at the moment shares are sold. (sec.gov) (ey.com) The clearest read on April 14, 2026 is that the window has reopened without fully widening. Companies are filing, roadshows are happening and bigger names are being discussed again, but the market is still rewarding preparation and timing more than ambition. (money.usnews.com) (pwc.co.uk)